We are live on
!
Find out more
Luther King Capital Management (LKCM) Portfolio holdings
AUM
$24.4B
1-Year Est. Return
22.19%
This Fund
S&P 500
This Quarter
Est. Return
-2.88%
1 Year Est. Return
+22.19%
3 Year Est. Return
+74.81%
5 Year Est. Return
+96.49%
10 Year Est. Return
+450.05%
AUM
$19.3B
AUM Growth
-$864M
(-4.3%)
Cap. Flow
-$44M
Cap. Flow
% of AUM
-0.23%
Top 10 Holdings %
Top 10 Hldgs %
30.78%
Holding
614
New
17
Increased
176
Reduced
219
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Albemarle
ALB
|
+$57.3M |
| 2 |
Eli Lilly
LLY
|
+$20.1M |
| 3 |
Teledyne Technologies
TDY
|
+$17.1M |
| 4 |
Fluor
FLR
|
+$11.6M |
| 5 |
GTLS
Chart Industries
GTLS
|
+$11.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FMC
FMC
|
+$58M |
| 2 |
US Bancorp
USB
|
+$21.1M |
| 3 |
Walt Disney
DIS
|
+$13.6M |
| 4 |
Keurig Dr Pepper
KDP
|
+$12.6M |
| 5 |
Estee Lauder
EL
|
+$11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.51% |
| 2 | Industrials | 18.88% |
| 3 | Healthcare | 13.91% |
| 4 | Financials | 8.62% |
| 5 | Consumer Discretionary | 7.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
301
Novo Nordisk
NVO
$203B
| $2.27M | 0.01% |
25,010
+11,852
| +90% | +$1.04M |
|
|
CALY
302
Callaway Golf Company
CALY
$2.95B
| $2.27M | 0.01% |
164,015
+21,003
| +15% | +$369K |
|
|
HES
303
DELISTED
Hess
HES
| $2.25M | 0.01% |
14,707
-55
| -0.4% | -$8.28K |
|
304
Paylocity
PCTY
$7.73B
| $2.24M | 0.01% |
12,334
-122
| -1% | -$24.5K |
|
|
EXAS
305
DELISTED
Exact Sciences
EXAS
| $2.24M | 0.01% |
32,770
-283
| -0.9% | -$24K |
|
306
Johnson Controls International
JCI
$92.6B
| $2.2M | 0.01% |
41,354
-180
| -0.4% | -$11.1K |
|
|
NVEE
307
DELISTED
NV5 Global
NVEE
| $2.19M | 0.01% |
90,872
+3,348
| +4% | +$86.3K |
|
308
Truist Financial
TFC
$64.3B
| $2.17M | 0.01% |
76,017
-3,423
| -4% | -$105K |
|
309
Schwab US Dividend Equity ETF
SCHD
$107B
| – | – |
0
| – | – |
|
310
Mine Safety
MSA
$7.41B
| $2.16M | 0.01% |
13,726
-136
| -1% | -$23.4K |
|
311
Idexx Laboratories
IDXX
$45B
| $2.12M | 0.01% |
4,851
-10
| -0.2% | -$4.99K |
|
312
Markel Group
MKL
$22.8B
| $2.12M | 0.01% |
1,439
| – | – |
|
313
First Financial Bankshares
FFIN
$5.01B
| $2.05M | 0.01% |
81,500
-128,500
| -61% | -$3.73M |
|
314
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.75B
| – | – |
0
| – | – |
|
315
Target
TGT
$69.9B
| $1.93M | 0.01% |
17,449
+750
| +4% | +$95.2K |
|
316
Middleby
MIDD
$5.38B
| $1.88M | 0.01% |
14,700
| – | – |
|
317
MSCI
MSCI
$40.9B
| $1.88M | 0.01% |
3,661
-105
| -3% | -$55.2K |
|
318
Upwork
UPWK
$1.05B
| $1.86M | 0.01% |
163,582
+6,663
| +4% | +$82.7K |
|
319
Trade Desk
TTD
$6.34B
| $1.81M | 0.01% |
23,169
| – | – |
|
|
VBTX
320
DELISTED
Veritex Holdings
VBTX
| $1.77M | 0.01% |
98,399
-8,691
| -8% | -$168K |
|
321
FTAI Infrastructure
FIP
$533M
| $1.76M | 0.01% |
547,490
-10,400
| -2% | -$35.9K |
|
322
Bristol-Myers Squibb
BMY
$130B
| $1.76M | 0.01% |
30,338
+2,080
| +7% | +$127K |
|
323
Invesco QQQ Trust
QQQ
$481B
| $1.75M | 0.01% |
4,883
-100
| -2% | -$37.1K |
|
|
TWNK
324
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $1.71M | 0.01% |
51,291
-89,505
| -64% | -$2.4M |
|
325
TE Connectivity
TEL
$62B
| $1.7M | 0.01% |
13,737
| – | – |
|
Similar funds
JG
OAG
Luther King Capital Management (LKCM)'s Q3 2023 Portfolio in Review
As of Q3 2023, Luther King Capital Management (LKCM) held 614 positions worth $19.3B, down 4.3% from $20.1B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Luther King Capital Management (LKCM)'s Q3 2023 filing shows 17 new, 176 increased, 219 reduced and 27 closed positions. Its largest new stake was Fluor: 345,940 shares worth $12.7M. The largest sale was FMC, an estimated $58M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Industrials and Healthcare.
- Luther King Capital Management (LKCM)'s largest Q3 2023 buy was Fluor: 345,940 shares worth $12.7M.
- Luther King Capital Management (LKCM) added most to Albemarle in Q3 2023, an estimated $57.3M increase.
- Luther King Capital Management (LKCM)'s biggest Q3 2023 reduction was FMC, cutting an estimated $58M.
- Luther King Capital Management (LKCM) fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $6.68M.
- Luther King Capital Management (LKCM)'s ten largest holdings make up 31% of its $19.3B portfolio in Q3 2023.
- Luther King Capital Management (LKCM) opened 17 new positions and closed 27 in Q3 2023.
- Luther King Capital Management (LKCM)'s portfolio value fell 4.3% quarter-over-quarter to $19.3B.
Based on Luther King Capital Management (LKCM)'s 13F filing for Q3 2023, filed 13 Nov 2023.